Point72 Asset Management’s Arcutis Biotherapeutics ARQT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $20.8M | Buy |
1,485,425
+654,947
| +79% | +$9.18M | 0.04% | 404 |
|
|
2025
Q1 | $13M | Sell |
830,478
-923,044
| -53% | -$14.4M | 0.03% | 474 |
|
|
2024
Q4 | $24.4M | Buy |
1,753,522
+1,509,136
| +618% | +$21M | 0.05% | 353 |
|
|
2024
Q3 | $2.27M | Buy |
+244,386
| New | +$2.27M | 0.01% | 728 |
|
|
2024
Q1 | – | Sell |
-320,300
| Closed | -$1.03M | – | 1429 |
|
|
2023
Q4 | $1.03M | Buy |
+320,300
| New | +$1.03M | ﹤0.01% | 916 |
|
|
2023
Q1 | – | Sell |
-1,103,576
| Closed | -$16.3M | – | 1683 |
|
|
2022
Q4 | $16.3M | Sell |
1,103,576
-2,681,701
| -71% | -$39.7M | 0.06% | 371 |
|
|
2022
Q3 | $72.3M | Buy |
3,785,277
+1,797,846
| +90% | +$34.4M | 0.29% | 81 |
|
|
2022
Q2 | $42.4M | Buy |
1,987,431
+289,582
| +17% | +$6.17M | 0.18% | 146 |
|
|
2022
Q1 | $32.7M | Sell |
1,697,849
-946,328
| -36% | -$18.2M | 0.13% | 190 |
|
|
2021
Q4 | $54.8M | Buy |
2,644,177
+652,070
| +33% | +$13.5M | 0.22% | 115 |
|
|
2021
Q3 | $47.6M | Buy |
1,992,107
+1,095,707
| +122% | +$26.2M | 0.21% | 112 |
|
|
2021
Q2 | $24.5M | Buy |
896,400
+457,100
| +104% | +$12.5M | 0.11% | 226 |
|
|
2021
Q1 | $12.7M | Sell |
439,300
-435,900
| -50% | -$12.6M | 0.06% | 357 |
|
|
2020
Q4 | $24.6M | Buy |
875,200
+831,944
| +1,923% | +$23.4M | 0.12% | 222 |
|
|
2020
Q3 | $1.27M | Buy |
+43,256
| New | +$1.27M | 0.01% | 698 |
|